GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
114 hedge funds and large institutions have $357M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $541M → $357M (-$183M)
Holders
114
Holding in Top 10
–
Calls
$2.8M
Puts
$2.47M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$11M | |
| 3 | +$4.88M | |
| 4 |
Goldman Sachs
New York
|
+$3.28M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$2.85M |
Top Sellers
| 1 | -$8.77M | |
| 2 | -$7.26M | |
| 3 | -$6.45M | |
| 4 |
Morgan Stanley
New York
|
-$3.03M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.97M |